TKNO
Alpha Teknova Inc
NASDAQ: TKNO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$7.79
+4.56% today
Updated 2026-09-18
Market cap
$418.23M
P/E ratio
—
P/S ratio
9.57x
EPS (TTM)
$-0.31
Dividend yield
—
52W range
$2 – $8
Volume
0.2M
Alpha Teknova Inc (TKNO) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$7.79
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 5.30% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -38.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.